Diff between cefadoxime cefuraxime cefparzone which antibitoic will use and for what condition

Reading File
Now let me search the medical library for all three cephalosporins in parallel.
Finding Sources
Finding Sources
Finding Sources
Now let me read the detailed sections from the textbooks:
Reading File
Reading File
I now have detailed information from multiple textbooks. Let me read the clinical uses section for a more complete picture:
Reading File
Reading File
I now have comprehensive information from the textbooks. Let me compose a thorough answer.

Cefadroxil vs Cefuroxime vs Cefoperazone - A Complete Comparison

(Note: You likely meant cefadroxil for "cefadoxime," cefuroxime for "cefuraxime," and cefoperazone for "cefparzone" - these are the correct drug names.)

At a Glance

FeatureCefadroxilCefuroximeCefoperazone
Generation1st generation2nd generation3rd generation
RouteOral onlyOral (axetil) / IV / IMIV / IM only
SpectrumNarrow (gram+)IntermediateBroad (gram+ and gram-)
Pseudomonas activityNoneNoneYes (some)
Biliary excretionNoNoYes (primary)

1. Cefadroxil (1st Generation)

Spectrum:
  • Excellent gram-positive coverage: Streptococci, Staphylococci (MSSA, not MRSA)
  • Limited gram-negative: only E. coli, Klebsiella pneumoniae, Proteus mirabilis
  • No Pseudomonas, no Bacteroides fragilis
  • Oral agent similar in activity and pharmacokinetics to cephalexin
Pharmacokinetics:
  • Oral administration; well absorbed
  • Renally excreted - dose reduction needed in renal failure
Clinical Uses:
  • Uncomplicated skin and soft tissue infections (impetigo, folliculitis, cellulitis, erysipelas, ecthyma)
  • Uncomplicated UTIs caused by E. coli, Klebsiella, Proteus
  • Streptococcal pharyngitis / tonsillitis
  • Mild community-acquired wound infections
"A first-generation agent such as cephalexin or cefadroxil is the cephalosporin of choice in uncomplicated skin infections." - Dermatology 2-Volume Set 5e

2. Cefuroxime (2nd Generation)

Spectrum:
  • Moderately active against gram-positive cocci (but less than 1st gen)
  • Improved gram-negative coverage including H. influenzae (including ampicillin-resistant strains), N. meningitidis, S. pneumoniae, E. coli, Klebsiella
  • Does NOT cover B. fragilis (unlike cefoxitin/cefotetan)
  • No Pseudomonas activity
Pharmacokinetics:
  • Available as cefuroxime (IV/IM) and cefuroxime axetil (oral, 30-50% absorbed)
  • ~10% penetrates CSF - can treat meningitis but inferior to ceftriaxone
  • Renally cleared; dose adjust in renal failure
Clinical Uses:
  • Community-acquired pneumonia (active against H. influenzae and pneumococci)
  • Sinusitis, otitis media
  • Surgical prophylaxis (cardiac, orthopedic, hysterectomy)
  • Lyme disease
  • Acute cholecystitis / biliary infections
  • Not recommended for meningitis despite CSF penetration (ceftriaxone is preferred)
"Cefuroxime is sometimes used to treat community-acquired pneumonia because it is active against β-lactamase-producing H. influenzae and also many pneumococci." - Katzung's Basic and Clinical Pharmacology, 16th Ed.

3. Cefoperazone (3rd Generation)

Spectrum:
  • Broadest of the three
  • Active against most Enterobacterales, Citrobacter, Serratia, Providencia
  • Useful activity against Pseudomonas aeruginosa (shared only with ceftazidime among 3rd-gen agents)
  • Less active against gram-positive cocci compared to 1st/2nd gen
  • Active against many β-lactamase-producing H. influenzae and Neisseria
Pharmacokinetics:
  • IV/IM only (no oral form)
  • Primarily biliary (hepatic) excretion - NO dose adjustment needed in renal failure; dose adjust in hepatic failure
  • This biliary route causes more diarrhea than other cephalosporins
  • Contains methylthiotetrazole ring - can cause hypoprothrombinemia (vitamin K-dependent bleeding) and disulfiram-like reaction with alcohol
  • No longer commercially available in the USA (still used widely outside the US)
Clinical Uses:
  • Hospital-acquired gram-negative bacteremia
  • Biliary tract infections and acute cholangitis
  • Serious intra-abdominal infections
  • Pseudomonal infections (when ceftazidime is unavailable)
  • Klebsiella and other hospital-acquired gram-negative infections (often used as cefoperazone-sulbactam combination)
  • Severe melioidosis (Burkholderia pseudomallei)
"For Pseudomonas aeruginosa, ceftazidime or cefoperazone may succeed. Thus, third-generation drugs are very useful in the management of hospital-acquired gram-negative bacteremia." - Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Ed.

When to Use Which

Clinical SituationDrug of Choice
Strep throat, mild skin/soft tissue infectionCefadroxil (oral, 1st gen)
Uncomplicated UTI (outpatient)Cefadroxil
Community-acquired pneumoniaCefuroxime
Otitis media, sinusitisCefuroxime (oral axetil)
Surgical prophylaxisCefuroxime (IV)
Lyme diseaseCefuroxime (oral)
Hospital-acquired gram-negative infectionCefoperazone (3rd gen)
Pseudomonal infectionCefoperazone (or ceftazidime)
Biliary tract / cholangitisCefoperazone (hepatic excretion)
Intra-abdominal (with Pseudomonas risk)Cefoperazone-sulbactam

Key Safety Points

  • Cefadroxil: safe, well tolerated, dose-adjust in renal failure
  • Cefuroxime: avoid in meningitis (use ceftriaxone instead)
  • Cefoperazone: watch for bleeding risk (give vitamin K), avoid alcohol (disulfiram reaction), monitor LFTs in hepatic impairment
Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. | Goodman & Gilman's The Pharmacological Basis of Therapeutics | Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Ed. | Dermatology 2-Volume Set 5e
This is a shared conversation. Sign in to Orris to start your own chat.